Logo image of CUTR

CUTERA INC (CUTR) Stock Fundamental Analysis

NASDAQ:CUTR - Nasdaq - US2321091082 - Common Stock - Currency: USD

0.0969  -0.01 (-10.19%)

After market: 0.0381 -0.06 (-60.68%)

Fundamental Rating

1

Taking everything into account, CUTR scores 1 out of 10 in our fundamental rating. CUTR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. CUTR may be in some trouble as it scores bad on both profitability and health. CUTR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CUTR had negative earnings in the past year.
CUTR had a negative operating cash flow in the past year.
In the past 5 years CUTR reported 4 times negative net income.
In the past 5 years CUTR reported 4 times negative operating cash flow.
CUTR Yearly Net Income VS EBIT VS OCF VS FCFCUTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -61.31%, CUTR is doing worse than 73.02% of the companies in the same industry.
Industry RankSector Rank
ROA -61.31%
ROE N/A
ROIC N/A
ROA(3y)-20.69%
ROA(5y)-18.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CUTR Yearly ROA, ROE, ROICCUTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

CUTR's Gross Margin of 5.93% is on the low side compared to the rest of the industry. CUTR is outperformed by 82.01% of its industry peers.
In the last couple of years the Gross Margin of CUTR has declined.
The Profit Margin and Operating Margin are not available for CUTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.52%
GM growth 5Y-16.94%
CUTR Yearly Profit, Operating, Gross MarginsCUTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

CUTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CUTR has been increased compared to 1 year ago.
The number of shares outstanding for CUTR has been increased compared to 5 years ago.
CUTR has a worse debt/assets ratio than last year.
CUTR Yearly Shares OutstandingCUTR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CUTR Yearly Total Debt VS Total AssetsCUTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

CUTR has an Altman-Z score of -3.16. This is a bad value and indicates that CUTR is not financially healthy and even has some risk of bankruptcy.
CUTR has a worse Altman-Z score (-3.16) than 64.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC2.27%
CUTR Yearly LT Debt VS Equity VS FCFCUTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

CUTR has a Current Ratio of 2.88. This indicates that CUTR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.88, CUTR is in line with its industry, outperforming 52.91% of the companies in the same industry.
A Quick Ratio of 1.86 indicates that CUTR should not have too much problems paying its short term obligations.
CUTR has a Quick ratio (1.86) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.86
CUTR Yearly Current Assets VS Current LiabilitesCUTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CUTR have decreased strongly by -53.75% in the last year.
Looking at the last year, CUTR shows a very negative growth in Revenue. The Revenue has decreased by -32.53% in the last year.
CUTR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.47% yearly.
EPS 1Y (TTM)-53.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.73%
Revenue 1Y (TTM)-32.53%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Sales Q2Q%-30.07%

3.2 Future

Based on estimates for the next years, CUTR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.52% on average per year.
CUTR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.29% yearly.
EPS Next Y-15.64%
EPS Next 2Y12.13%
EPS Next 3Y12.16%
EPS Next 5Y10.52%
Revenue Next Year-32.88%
Revenue Next 2Y-16.2%
Revenue Next 3Y-7.65%
Revenue Next 5Y4.29%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CUTR Yearly Revenue VS EstimatesCUTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CUTR Yearly EPS VS EstimatesCUTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CUTR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CUTR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CUTR Price Earnings VS Forward Price EarningsCUTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUTR Per share dataCUTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as CUTR's earnings are expected to grow with 12.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.13%
EPS Next 3Y12.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CUTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUTERA INC

NASDAQ:CUTR (3/12/2025, 8:00:00 PM)

After market: 0.0381 -0.06 (-60.68%)

0.0969

-0.01 (-10.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners33.67%
Inst Owner Change-96.05%
Ins Owners0.61%
Ins Owner Change0%
Market Cap1.96M
Analysts80
Price Target2.04 (2005.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-46.13%
Min EPS beat(2)-70.55%
Max EPS beat(2)-21.7%
EPS beat(4)1
Avg EPS beat(4)-25.35%
Min EPS beat(4)-70.55%
Max EPS beat(4)31.14%
EPS beat(8)2
Avg EPS beat(8)-27.63%
EPS beat(12)3
Avg EPS beat(12)-73.2%
EPS beat(16)7
Avg EPS beat(16)33.41%
Revenue beat(2)0
Avg Revenue beat(2)-6.8%
Min Revenue beat(2)-12.9%
Max Revenue beat(2)-0.69%
Revenue beat(4)2
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-12.9%
Max Revenue beat(4)2.25%
Revenue beat(8)2
Avg Revenue beat(8)-4.68%
Revenue beat(12)3
Avg Revenue beat(12)-2.87%
Revenue beat(16)7
Avg Revenue beat(16)1.32%
PT rev (1m)0%
PT rev (3m)33.33%
EPS NQ rev (1m)9.18%
EPS NQ rev (3m)9.18%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.92
EYN/A
EPS(NY)-3.3
Fwd EYN/A
FCF(TTM)-5.96
FCFYN/A
OCF(TTM)-5.78
OCFYN/A
SpS7.69
BVpS-12.52
TBVpS-12.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.93%
FCFM N/A
ROA(3y)-20.69%
ROA(5y)-18.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.52%
GM growth 5Y-16.94%
F-Score2
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.64%
Cap/Sales 2.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.88
Quick Ratio 1.86
Altman-Z -3.16
F-Score2
WACC2.27%
ROIC/WACCN/A
Cap/Depr(3y)442.5%
Cap/Depr(5y)296.69%
Cap/Sales(3y)8.33%
Cap/Sales(5y)5.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.73%
EPS Next Y-15.64%
EPS Next 2Y12.13%
EPS Next 3Y12.16%
EPS Next 5Y10.52%
Revenue 1Y (TTM)-32.53%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Sales Q2Q%-30.07%
Revenue Next Year-32.88%
Revenue Next 2Y-16.2%
Revenue Next 3Y-7.65%
Revenue Next 5Y4.29%
EBIT growth 1Y-45.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.52%
EBIT Next 3Y16.97%
EBIT Next 5Y15.93%
FCF growth 1Y-94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-146.55%
OCF growth 3YN/A
OCF growth 5YN/A